Biotech Values

[DewDiligence]

>How many small companies are getting funding these days?<

Almost none. The crappy companies can’t get funding for the reasons discussed in #msg-33838374.

>If they didn't have something special, they wouldn't be getting the money.<

MNTA is indeed sui generis, which begs the question of whom they might acquire with the new money—assuming for the sake of discussion that they are actually on the prowl.